Leaders In Conversation

Creating a healthier Singapore with digital solutions: Q&A with Glenn Neo

In this insightful interview, Karen Yu, Country Manager for Roche Diagnostics Singapore, sits down with Glenn Neo, Director of Innovation and Capabilities Enablement (ICE) at Synapxe, the national HealthTech agency of Singapore, for a wide-ranging conversation. Together, they explore the vital role of technology in enhancing healthcare services in Singapore, the potential of generative AI, […]

Creating a healthier Singapore with digital solutions: Q&A with Glenn Neo Read More »

Growing one of Indonesia’s largest laboratory chains: Q&A with Dr Dewi Muliaty 

Growing one of Indonesia’s largest laboratory chains: Q&A with Dr Dewi Muliaty 

When she first joined PT Prodia over 20 years ago, now President Director Dr Dewi Muliaty reflects on how the company has grown from a small collection of 9 branches to one of the largest commercial laboratory groups in Indonesia. In this interview with Mr Lee Poh Seng, Director, Diagnostics Division, PT Roche Indonesia, they

Growing one of Indonesia’s largest laboratory chains: Q&A with Dr Dewi Muliaty  Read More »

Advancing diagnostics in Pakistan with total lab automation: Q&A with Dr Rizwan Uppal

Advancing diagnostics in Pakistan with total lab automation Q&A with Dr Rizwan Uppal_thumbnail

As one of the largest providers of diagnostic services in Pakistan, Islamabad Diagnostics Centre (IDC) performs more than 7 million tests annually across 130 branches in the country. Chairman, Founder & CEO, Dr Rizwan Uppal sits down with Mr Abdul Qayyum, Country Manager of Roche Diagnostics Pakistan, and talks about the establishment of the IDC

Advancing diagnostics in Pakistan with total lab automation: Q&A with Dr Rizwan Uppal Read More »

Awanui Group’s quest to improve lab diagnostics in New Zealand: Q&A with Anoop Singh (Part 1)

How Awanui Group drives diagnostic excellence in New Zealand: Q&A with Anoop Singh (Part 1)

As CEO of Awanui Group, Anoop Singh looks after one of the most important institutions in New Zealand’s laboratory medicine ecosystem. In this Q&A with Wing Lam Wong, General Manager of Roche Diagnostics New Zealand, Singh introduces his organisation and discusses how partnerships with IVD suppliers, community groups, governmental entities and other key stakeholders are

Awanui Group’s quest to improve lab diagnostics in New Zealand: Q&A with Anoop Singh (Part 1) Read More »

Accelerating environmental sustainability in clinical labs: Q&A with Prof Tony Badrick

Accelerating environmental sustainability in clinical labs Q&A with Prof Tony Badrick_thumbnail

The Lab Insights team recently caught up with Professor Tony Badrick, sitting President of the Asia Pacific Federation for Clinical Biochemistry and Laboratory Medicine (APFCB), to discuss his work at the helm of IFCC’s Environmental Impact of Laboratory Medicine task force. As Chair of the task force, he aims to work with all stakeholders to

Accelerating environmental sustainability in clinical labs: Q&A with Prof Tony Badrick Read More »

BabySeq, ICoNS and the power of newborn sequencing: Q&A with Dr Robert Green

BabySeq, ICoNS and the power of newborn sequencing: Q&A with Dr Robert Green

Dr Robert Green is a physician-scientist who has spent much of his career at the forefront of the exciting field of translational genomics. In this Q&A with Will Greene, Healthcare Engagement Lead at Roche Diagnostics Asia Pacific, Dr Green talks about his pioneering work in newborn sequencing, including via the BabySeq project and the International

BabySeq, ICoNS and the power of newborn sequencing: Q&A with Dr Robert Green Read More »

Mass spectrometry for routine clinical testing: Q&A with Prof Junghan Song

The power of clinical mass spectrometry: Q&A with Prof Junghan Song

As President & CEO of Seoul National University Bundang Hospital (SNUBH), Prof Junghan Song leads one of Korea’s most important healthcare institutions. His scope of responsibility includes oversight of the SNUBH lab, which currently uses mass spectrometry for routine clinical testing, including drug analysis, toxicology assessment, biochemical genetics testing, analysis of diverse metabolites, and some

Mass spectrometry for routine clinical testing: Q&A with Prof Junghan Song Read More »

Dr Sharad Paul on skin health, cancer, and the evolving role of pathology

Dr Sharad Paul on skin health, cancer and the evolving role of pathology_thumbnail

Dr Sharad Paul is a New Zealand-based skin cancer specialist, social entrepreneur, and author. In this Q&A with Chitra Nair, APAC Pathology Lead at Roche Diagnostics Asia Pacific, he shares his thoughts on key issues in skin health management and what they mean for the practice of laboratory medicine, drawing upon his vast clinical experience,

Dr Sharad Paul on skin health, cancer, and the evolving role of pathology Read More »

Genomic newborn screening and the BeginNGS project: Q&A with Dr Stephen Kingsmore (Part 2)

kingsmore thumb 2

Rady Children’s Institute for Genomic Medicine (RCIGM) is widely regarded as a key player in the global ecosystem of research groups that are exploring the role of whole genome sequencing for newborn screening. In this Q&A with Will Greene, Healthcare Engagement Lead for Roche Diagnostics Asia Pacific, RCIGM President & CEO Dr Stephen Kingsmore provides

Genomic newborn screening and the BeginNGS project: Q&A with Dr Stephen Kingsmore (Part 2) Read More »

Scroll to Top